KLK3 and urogenital neoplasm: Of the 1705 CHAMP participants, 672 were excluded from this analysis because of self-reported prostatitis (n = 154), having received treatment for prostate disease (n = 383), and missing age, BMI, PSA, serum 25OHD, region of birth or SNP-typing results (n = 135).